| 2024-05-13 | Sale | G1 Therapeutics, Inc. GTHX | President and CEO | 37,258 0.0739% | $4.79 | $178,421 | -30.3% | |
| 2024-01-03 | Sale | G1 Therapeutics, Inc. GTHX | President and CEO | 11,686 0.0235% | $3.12 | $36,447 | +24.83% | |
| 2024-01-02 | Sale | G1 Therapeutics, Inc. GTHX | President and CEO | 32,983 0.0674% | $3.27 | $108,006 | +19.07% | |
| 2023-07-05 | Sale | G1 Therapeutics, Inc. GTHX | President and CEO | 2,719 0.0052% | $2.45 | $6,672 | +2.21% | |
| 2023-01-04 | Sale | G1 Therapeutics, Inc. GTHX | President and CEO | 5,607 0.0111% | $5.58 | $31,262 | -52.75% | |
| 2023-01-03 | Sale | G1 Therapeutics, Inc. GTHX | President and CEO | 32,019 0.0633% | $5.85 | $187,452 | -55.06% | |
| 2022-01-03 | Sale | G1 Therapeutics, Inc. GTHX | President and CEO | 34,125 0.0779% | $10.41 | $355,262 | -21.89% | |
| 2020-11-11 | G1 Therapeutics, Inc. GTHX | director | 8,000 0.0214% | $12.83 | $102,640 | +58.14% | ||
| 2020-11-10 | G1 Therapeutics, Inc. GTHX | director | 8,000 0.0208% | $12.80 | $102,375 | +54.1% |